823 IMM20059, a novel anti-EPN1 antibody, in combination with atezolizumab significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy

Autor:	John Dowling, Pavel Nikitin, Cezary Swider, Chris Nicolescu, Halley Shukla, Jamie Bingaman-Steele, Nirja Patel, Eden Sikorski, Benjamin Harman, Jillian DiMuzio, Karen Lundgren, Yumi Ohtani, Michael Morin, Matthew Robinson, Fang Shen
Rok vydání:	2022
Zdroj:	Regular and Young Investigator Award Abstracts.
DOI:	10.1136/jitc-2022-sitc2022.0823
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7fea737a0bf0bd9419649e65c36ecccf https://doi.org/10.1136/jitc-2022-sitc2022.0823 Zobrazit plný text záznamu